Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biocatalytic method for R-mandelic acid production. High purity over 99 percent, cost-effective, scalable process for pharmaceutical supply chains.
Patent CN117402920A details a novel ketoreductase mutant for asymmetric reduction. This report analyzes cost reduction in chiral drug manufacturing and supply chain reliability for global buyers.
Advanced process for D-tyrosine production using tartrate resolution. Offers superior cost efficiency and scalability for pharmaceutical intermediate manufacturing compared to enzymatic methods.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.